PCM
SRTA

Prelude Capital Management’s Strata Critical Medical Inc SRTA Stock Holding History

Prelude Capital Management’s Portfolio SRTA Stock Details SRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.26M Sell
539,510
-52,869
-9% -$254K 0.17% 140
2025
Q4 		$2.85M Sell
592,379
-7,842
-1% -$37.9K 0.21% 104
2025
Q3 		$3.04M Sell
600,221
-291,249
-33% -$1.29M 0.24% 87
2025
Q2 		$3.59M Buy
+891,470
New +$2.9M 0.35% 54
2024
Q4 		– Sell
-48,003
Closed -$141K – 1236
2024
Q3 		$141K Sell
48,003
-4,307
-8% -$13.7K 0.01% 1121
2024
Q2 		$182K Buy
52,310
+28,210
+117% +$94.1K 0.01% 1026
2024
Q1 		$68.7K Buy
+24,100
New +$74.4K ﹤0.01% 1234

Other funds holding SRTA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NRCM
Northern Right Capital Management Darien, Connecticut $281M AUM 56.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
PLC
Pillsbury Lake Capital San Francisco, California $221M AUM
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Prelude Capital Management's SRTA Position: Q1 2026 in Review

Prelude Capital Management reduced its Strata Critical Medical Inc (SRTA) stake by 8.9% in Q1 2026, selling an estimated $254K and leaving 539,510 shares worth $2.26M. The position accounts for 0.17% of the portfolio, ranked #140.

Prelude Capital Management first reported a position in SRTA in Q1 2024 and has held it in 7 quarters since. The position peaked at $3.59M in Q2 2025. 125 funds tracked by Wall St. Rank hold SRTA as of Q1 2026.

  • Prelude Capital Management held 539,510 shares of Strata Critical Medical Inc worth $2.26M as of Q1 2026.
  • Prelude Capital Management sold 52,869 Strata Critical Medical Inc shares in Q1 2026, an estimated $254K.
  • Strata Critical Medical Inc made up 0.17% of Prelude Capital Management's portfolio in Q1 2026, its #140 holding.
  • Prelude Capital Management first reported a position in Strata Critical Medical Inc in Q1 2024 and has held it in 7 quarters since.
  • Prelude Capital Management's Strata Critical Medical Inc position peaked at $3.59M in Q2 2025.
  • 125 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q1 2026.

Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.